Amundi
AVNS

Amundi’s Avanos Medical AVNS Stock Holding History

Amundi’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,158
Closed -$255K – 1705
2025
Q1 		$255K Sell
18,158
-4,866
-21% -$76K ﹤0.01% 1629
2024
Q4 		$355K Buy
23,024
+15,359
+200% +$304K ﹤0.01% 1628
2024
Q3 		$172K Buy
7,665
+695
+10% +$15.9K ﹤0.01% 1682
2024
Q2 		$135K Buy
+6,970
New +$136K ﹤0.01% 1659
2023
Q2 		– Sell
-6,315
Closed -$192K – 2036
2023
Q1 		$192K Buy
+6,315
New +$183K ﹤0.01% 1577

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Amundi's AVNS Position: Q2 2025 in Review

Amundi sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 18,158 shares — an estimated $255K sold.

Amundi first reported a position in AVNS in Q1 2023 and held it in 5 quarters. The position peaked at $355K in Q4 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • Amundi reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 18,158 Avanos Medical shares in Q2 2025, an estimated $255K.
  • Amundi first reported a position in Avanos Medical in Q1 2023 and held it in 5 quarters.
  • Amundi's Avanos Medical position peaked at $355K in Q4 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.